John Wells
Hematology & Oncology · Fort Smith, ARNPI 1174532469
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 313 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for hematology & oncology clinicians in AR, where the typical reported total is $4,667.
Across 313 payments — averaging $16.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$732
- Amgen$669
- AstraZeneca$406
- E.r. Squibb & Sons, L.L.C.$333
- Eisai Inc.$273
- Rigel Pharmaceuticals, Inc.$239
- plus $2K from 30 others
What the payments were for
- Food & beverage$5,07999%
- Education$691%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 45 | $732 |
| Amgen | 38 | $669 |
| AstraZeneca | 26 | $406 |
| E.r. Squibb & Sons, L.L.C. | 28 | $333 |
| Eisai Inc. | 15 | $273 |
| Rigel Pharmaceuticals, Inc. | 13 | $239 |
| Beigene USA, Inc. | 17 | $233 |
| Bristol Myers Squibb | 14 | $213 |
| Regeneron Healthcare Solutions, Inc. | 9 | $201 |
| Novartis | 11 | $188 |
| Lilly USA, LLC | 8 | $185 |
| Coherus Oncology, Inc. | 10 | $163 |
| Pfizer | 10 | $153 |
| Exelixis Inc. | 9 | $148 |
| Seagen Inc. | 9 | $144 |
| Sanofi | 7 | $127 |
| Bayer | 7 | $111 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $72 |
| Incyte Corporation | 4 | $71 |
| Genentech USA, Inc. | 4 | $63 |
| Clovis Oncology, Inc. | 4 | $60 |
| Sun Pharmaceutical Industries Inc. | 3 | $47 |
| CTI Biopharma Corp. | 2 | $38 |
| Gilead | 2 | $38 |
| Dendreon Pharmaceuticals LLC | 2 | $34 |
| G1 Therapeutics, Inc. | 2 | $28 |
| Johnson & Johnson | 2 | $23 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
| Karyopharm Therapeutics Inc. | 1 | $21 |
| Morphosys, US Inc. | 1 | $18 |
| Array Biopharma Inc | 1 | $17 |
| EMD Serono, Inc. | 1 | $16 |
| Kyowa Kirin, Inc. | 1 | $16 |
| Puma Biotechnology, Inc. | 1 | $13 |
| ADC Therapeutics America, Inc. | 1 | $12 |
How this compares
$5,148 in reported general payments places this provider in the 50th percentile of 92 hematology & oncology providers in Arkansas.
Other hematology & oncology in Fort Smith
- Isam Abdel-KarimFort Smith$199K
- Humdum DurraniFort Smith$54K
- Narender GorukantiFort Smith$20K
- Varant ArzoumanianFort Smith$7K
- Daniel MackeyFort Smith$6K
- Aswanth ReddyFort Smith$5K
- Daniel MilesFort Smith$2K
- Suma Sri ChennapragadaFort Smith$2K
- Eric SchaeferFayetteville$466K
- Frits van RheeLittle Rock$218K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.